Monitoring of breast cancer progression via aptamer-based detection of circulating tumor cells in clinical blood samples.

Introduction: Breast cancer (BC) diagnostics lack noninvasive methods and procedures for screening and monitoring disease dynamics. Admitted CellSearch® is used for fluid biopsy and capture of circulating tumor cells of only epithelial origin. Here we describe an RNA aptamer (MDA231) for detecting BC cells in clinical samples, including blood. The MDA231 aptamer was originally selected against triple-negative breast cancer cell line MDA-MB-231 using cell-SELEX. Methods: The aptamer structure in solution was predicted using mFold program and molecular dynamic simulations. The affinity and specificity of the evolved aptamers were evaluated by flow cytometry and laser scanning microscopy on clinical tissues from breast cancer patients. CTCs were isolated form the patients' blood using the developed method of aptamer-based magnetic separation. Breast cancer origin of CTCs was confirmed by cytological, RT-qPCR and Immunocytochemical analyses. Results: MDA231 can specifically recognize breast cancer cells in surgically resected tissues from patients with different molecular subtypes: triple-negative, Luminal A, and Luminal B, but not in benign tumors, lung cancer, glial tumor and healthy epithelial from lungs and breast. This RNA aptamer can identify cancer cells in complex cellular environments, including tumor biopsies (e.g., tumor tissues vs. margins) and clinical blood samples (e.g., circulating tumor cells). Breast cancer origin of the aptamer-based magnetically separated CTCs has been proved by immunocytochemistry and mammaglobin mRNA expression. Discussion: We suggest a simple, minimally-invasive breast cancer diagnostic method based on non-epithelial MDA231 aptamer-specific magnetic isolation of circulating tumor cells. Isolated cells are intact and can be utilized for molecular diagnostics purposes.

The English (H6R) Mutation of the Alzheimer's Disease Amyloid-ß Peptide Modulates Its Zinc-Induced Aggregation.

The coordination of zinc ions by histidine residues of amyloid-beta peptide (Aß) plays a critical role in the zinc-induced Aß aggregation implicated in Alzheimer's disease (AD) pathogenesis. The histidine to arginine substitution at position 6 of the Aß sequence (H6R, English mutation) leads to an early onset of AD. Herein, we studied the effects of zinc ions on the aggregation of the Aß42 peptide and its isoform carrying the H6R mutation (H6R-Aß42) by circular dichroism spectroscopy, dynamic light scattering, turbidimetric and sedimentation methods, and bis-ANS and thioflavin T fluorescence assays. Zinc ions triggered the occurrence of amorphous aggregates for both Aß42 and H6R-Aß42 peptides but with distinct optical properties. The structural difference of the formed Aß42 and H6R-Aß42 zinc-induced amorphous aggregates was also supported by the results of the bis-ANS assay. Moreover, while the Aß42 peptide demonstrated an increase in the random coil and ß-sheet content upon complexing with zinc ions, the H6R-Aß42 peptide showed no appreciable structural changes under the same conditions. These observations were ascribed to the impact of H6R mutation on a mode of zinc/peptide binding. The presented findings further advance the understanding of the pathological role of the H6R mutation and the role of H6 residue in the zinc-induced Aß aggregation.

Heparin Modulates the Kinetics of Zinc-Induced Aggregation of Amyloid-ß Peptides.

Zinc-induced aggregation of amyloid-ß peptides (Aß) is considered to contribute to the pathogenesis of Alzheimer's disease. While glycosaminoglycans (GAGs) that are commonly present in interneuronal space are known to enhance Aß self-aggregation in vitro, the impact of GAGs on the formation of zinc-induced amorphous Aß aggregates has not yet been thoroughly studied. Here, employing dynamic light scattering, bis-ANS fluorimetry, and sedimentation assays, we demonstrate that heparin serving as a representative GAG modulates the kinetics of zinc-induced Aß42 aggregation in vitro by slowing the rate of aggregate formation and aggregate size growth. By using synthetic Aß16 peptides to model the Aß metal-binding domain (MBD), heparin was found to effectively interact with MBDs in complex with zinc ions. We suggest that heparin adsorbs to the surface of growing zinc-induced Aß42 aggregates via electrostatic interactions, thus creating a steric hindrance that inhibits further inclusion of monomeric and/or oligomeric zinc-Aß42 complexes. Furthermore, the adsorbed heparin can interfere with the zinc-bridging mechanism of Aß42 aggregation, requiring the formation of two zinc-mediated interaction interfaces in the MBD. As revealed by computer simulations of the zinc-Aß16 homodimer complexed with a heparin chain, heparin can interact with the MBD via polar contacts with residues Arg-5 and Tyr-10, resulting in a conformational rearrangement that hampers the formation of the second zinc-mediated interaction in the MBD interface. The findings of this study suggest that GAGs, which are common in the in vivo macromolecular environment, may have a substantial impact on the time course of zinc-induced Aß aggregation.

Zinc-Mediated Binding of Nucleic Acids to Amyloid-ß Aggregates: Role of Histidine Residues.

Amyloid-ß peptide (Aß) plays a central role in Alzheimer's disease (AD) pathogenesis. Besides extracellular Aß, intraneuronal Aß (iAß) has been suggested to contribute to AD onset and development. Based on reported in vitro Aß-DNA interactions and nuclear localization of iAß, the interference of iAß with the normal DNA expression has recently been proposed as a plausible pathway by which Aß can exert neurotoxicity. Employing the sedimentation assay, thioflavin T fluorescence, and dynamic light scattering we have studied effects of zinc ions on binding of RNA and single- and double-stranded DNA molecules to Aß42 aggregates. It has been found that zinc ions significantly enhance the binding of RNA and DNA molecules to pre-formed ß-sheet rich Aß42 aggregates. Another type of Aß42 aggregates, the zinc-induced amorphous aggregates, was demonstrated to also bind all types of nucleic acids tested. To evaluate the role of the Aß metal-binding domain's histidine residues in Aß-nucleic acid interactions mediated by zinc, Aß16 mutants with substitutions H6R and H6A-H13A and rat Aß16 lacking histidine residue 13 were used. The zinc-induced interaction of Aß16 with DNA was shown to critically depend on histidine residues 6 and 13. However, the inclusion of H6R mutation in Aß42 peptide did not affect DNA binding to Aß42 aggregates. Since oxidative and/or nitrosative stresses implicated in AD pathogenesis are known to release zinc ions from metallothioneins in cytoplasm and cell nuclei, our findings suggest that intracellular zinc can be an important player in iAß-nucleic acid interactions.